How Big is the Pegylation Market | Suppliers & Company list 2025

Code: MTA7847 Publication Date: Aug 2025

What is the size of Pegylation Market?

According to 6Wresearch internal database and industry insights, the Global Pegylation Market was estimated at USD 1.4 billion in 2024 and is projected to reach USD 2.3 billion by 2031, expanding at a CAGR of 6.10 % during the forecast period 2025-2031.

There are numbers of factors which are contributing in the expansion of landscape of the Pegylation Market include rising demand for advanced drug delivery systems, increasing prevalence of chronic diseases, and ongoing research in biologics and biosimilars.

Key Growth Drivers of the Pegylation Market

  • Rising adoption of pegylated drugs for enhanced therapeutic efficacy and stability
  • Increasing investments in pharmaceutical R&D for novel biologics
  • Growing use of PEGylation in oncology, hepatitis, and other chronic disease treatments
  • Technological advancements in PEGylation reagents and conjugation chemistry
  • Expansion of contract research and manufacturing organizations (CROs and CMOs)

Pegylation Market Trends

Pegylation market is moving forward with notable trends for instance the development of site-specific PEGylation techniques to improve the drug targeting. Other trends, for instance continuous improvements in polymer science are enabling better pharmacokinetics and reduced immunogenicity. Aside from these, pharmaceutical companies are increasingly using PEGylation to extend patent life and create differentiated drug offerings. Further, the strategic collaborations between biotech firms and contract manufacturers are becoming more common.

Emerging Developments in the Pegylation Market

Pegylation market is developing throughout the years as the market is introduced to biodegradable PEG derivatives to address long-term safety concerns. Developments, such as expansion of PEGylation applications into gene and cell therapies. The use of AI-driven predictive modelling is growing to design optimized PEG conjugates. This market is supported by regulatory approvals of PEGylated products across diverse therapeutic classes.

List of Leading Companies in the Pegylation Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Merck KGaA

Company NameMerck KGaA
Establishment Year1668
HeadquarterDarmstadt, Germany
Official WebsiteClick Here

This company provides PEGylation reagents and custom conjugation services and has a strong global footprint in pharmaceutical and life science solutions.

2. Thermo Fisher Scientific Inc.

Company NameThermo Fisher Scientific Inc.
Establishment Year2006
HeadquarterMassachusetts, United States
Official WebsiteClick Here

This company offers a range of PEGylation chemicals and kits for drug development and serves pharmaceutical, biotech, and academic research sectors.

3. NOF Corporation

Company NameNOF Corporation
Establishment Year1937
HeadquarterTokyo, Japan
Official WebsiteClick Here

This company specializes in activated PEG derivatives for pharmaceuticals and is known for innovation in site-specific PEGylation chemistry.

4. Quanta BioDesign, Ltd.

Company NameQuanta BioDesign, Ltd.
Establishment Year1999
HeadquarterOhio, United States
Official WebsiteClick Here

This company develops monodisperse PEG reagents for precise drug conjugation and serves both research and commercial manufacturing needs.

5. Creative PEGWorks

Company NameCreative PEGWorks
Establishment Year2007
HeadquarterNorth Carolina, United States
Official WebsiteClick Here

This company provides PEG reagents, polymers, and custom synthesis services and covers pharmaceutical, cosmetic, and biomaterials markets.

6. JenKem Technology Co., Ltd.

Company NameJenKem Technology Co., Ltd.
Establishment Year2001
HeadquarterBeijing, China
Official WebsiteClick Here

This company produces a wide variety of activated PEG derivatives and focuses on global supply for pharmaceutical PEGylation.

7. Laysan Bio, Inc.

Company NameLaysan Bio, Inc.
Establishment Year2005
HeadquarterAlabama, United States
Official WebsiteClick Here

This company manufactures high-purity PEG reagents and polymers and supplies to pharmaceutical, biotech, and research organizations.

8. SunBio, Inc.

Company NameSunBio, Inc.
Establishment Year1999
HeadquarterSouth Korea
Official WebsiteClick Here

This company provides specialty PEG derivatives for drug delivery applications and is recognized for expertise in PEGylation of peptides and proteins.

How Big is the Pegylation Market: FAQs

The Pegylation market was estimated at USD 1.4 billion in 2024 and is projected to reach USD 2.3 billion by 2031.
Growth factors include demand for advanced drug delivery, rise in chronic diseases, and PEGylation innovations.
Pharmaceuticals, biotechnology, and biologics manufacturing sectors lead adoption.
Key companies include Merck KGaA, Thermo Fisher Scientific, NOF Corporation, Quanta BioDesign, Creative PEGWorks, JenKem Technology, Laysan Bio, and SunBio.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All